An OSA screening protocol with home sleep apnea testing increased the OSA screening rate from 49.3% to 96.7% (p < .001) and sleep study completion from 2% to 25% (p < .001) in new AF patients.
Does an OSA screening protocol with home sleep apnea testing and PAP initiation improve OSA detection and treatment in new atrial fibrillation patients?
Implementing an EP clinic-coordinated OSA screening protocol with home sleep apnea testing significantly improved OSA screening and diagnosis rates in patients with atrial fibrillation.
Absolute Event Rate: 96.7% vs 49.3%
p-value: p=<.001
AbstractBackground Obstructive sleep apnea (OSA) contributes to negative cardiac remodeling and worsened atrial fibrillation (AF) outcomes, yet screening remains suboptimal despite guideline recommendations. Objective This quality improvement project aimed to improve screening, diagnosis, and treatment of OSA in AF patients. Methods A pre- and post-intervention design evaluated an OSA screening protocol with home sleep apnea testing (HSAT) and positive airway pressure (PAP) initiation for new AF patients in the electrophysiology (EP) clinic over 3 months. Patients were screened with an OSA questionnaire; those with elevated scores underwent HSAT coordinated by the EP clinic. Patients with moderate to severe OSA were initiated on PAP therapy. Results The sample included 141 patients (pre, n = 81; post, n = 60) with no significant baseline differences. The OSA screening rate increased from 49.3% to 96.7% (p p Conclusion This protocol with HSAT and PAP delivered by the EP clinic improved OSA detection and treatment. Further study is needed to understand the impact on patient outcomes.
Walker et al. (Fri,) conducted a other in Atrial fibrillation and obstructive sleep apnea (n=141). OSA screening protocol with home sleep apnea testing and PAP initiation vs. Pre-intervention standard care was evaluated on OSA screening rate (p=<.001). An OSA screening protocol with home sleep apnea testing increased the OSA screening rate from 49.3% to 96.7% (p < .001) and sleep study completion from 2% to 25% (p < .001) in new AF patients.